Queensland is becoming a globally competitive Asia-Pacific biomedical industry hub. Our technologies, products, systems and services are innovative, sustainable and embedded in local and global supply chains.
Queensland is home to a cluster of agile, innovative and entrepreneurial biomedical businesses. Our pre-clinical and early-phase clinical trial capabilities are underpinned by a world-class research base and state-of-the-art translational facilities.
Existing strengths and emerging capabilities include:
- vaccine development and delivery
- biopharmaceutical contract manufacturing
- microbiome analysis and development
- generic pharmaceuticals
- complementary medicines
- medical devices and diagnostics
- tropical health and medicine
- clinical trials
- digital health technologies such as:
- connected devices
- remote monitoring technology and point-of-care diagnostics
- wearable devices
Queensland's biomedical sector at a glance:
- A$2.11 billion estimated annual gross value added to the Queensland economy (March 2022)
- 12 400 people employed (March 2022)
- export value estimated at $450 million (March 2022)
- global expertise in tropical medicine and infectious diseases
- mature and emerging health and knowledge precincts
- established networks of top-tier industry support services
- expertise in e-health and telemedicine
- two decades of state government investment in science and innovation
- world-class research base, state-of-the-art translational research facilities and hospitals
- home to two of Australia's leading biopharmaceutical contract manufacturers
The Advance Queensland Biomedical 10-Year Roadmap and Action Plan highlights the collaborative approach between government and industry to further grow this priority sector, which is already a major employer and contributor to the state economy.
Find out more at DSDMIP.
Contact: TIQ - Contact